 |
|
Spinal muscular atrophy sufferers are a step closer to accessing vastly life-improving treatment following the formal National Institute for Health and Care Excellence (NICE) invitation to Biogen to submit SPINRAZA (nusinersen) for assessment via the Single Technology Appraisal route. Nusinersen is the first and currently only disease-modifying treatment for 5q spinal muscular atrophy.
|
|
 |
|
The nerve circuits that enable people to walk first appeared more than 400 million years ago in fish whose descendants still walk the seafloor on their fins. This is the finding of a study led by researchers from NYU School of Medicine and published online in the journal Cell. Past research had revealed that the fish species little skate (Leucoraja erinacea) displays alternating, left-right, two-limbed motion with its pelvic fins similar to that used by land animals.
|
|
 |
|
The Food and Drug Administration (FDA) has today issued the final rule on “human subject protection; acceptance of data from clinical investigations for medical devices”. The rule updates the FDA’s standards for accepting clinical data from clinical investigations conducted inside and outside the United States to help ensure the protection of human participants, to ensure data quality.
|
|
